Profil bibliographique

Carolina Rosswog

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

53Publications signalées

1945Citations signalées

3Affiliations récentes

Institutions déclarées

University of Cologne Institute of Experimental Endocrinology of the Slovak Academy of Sciences University Hospital Cologne

Domaines associés

Neuroblastoma Research and TreatmentsMitochondrial Function and PathologyMicrotubule and mitosis dynamicsCancer, Hypoxia, and MetabolismTelomeres, Telomerase, and Senescence

Publications récentes

Accès ouvert 2026 articleOpenAlex

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study

Hannah E. Hartley, Fang Chyi Fong, Alem S. Gabriel, Louise K. Stevenson et autres

0 citationsJCO Precision Oncology

Accès ouvert 2026 erratumOpenAlex

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study

Hannah E. Hartley, Fang Chyi Fong, Alem S. Gabriel, Louise K. Stevenson et autres

0 citationsJCO Precision Oncology

Accès ouvert 2026 articleOpenAlex

Telomere damage enhances immunogenicity of neuroblastoma and accelerates response to anti-PD-L1 treatment

Stefanie Höppner, Lisa Werr, Beata Szilagyi, Christoph Bartenhagen et autres

0 citationsOncoImmunology

Accès ouvert 2026 articleOpenAlex

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma

Lisa Werr, Jana Boland, Josephine Blaamann Petersen, Fiorella Iglesias et autres

0 citationsJournal of Clinical Investigation

Accès ouvert 2026 articleOpenAlex

Current treatment strategies for first relapse of high-risk neuroblastoma

S Castelli, Franziska Schulze, Theresa M. Thole-Kliesch, Kathy Astrahantseff et autres

6 citationsEuropean Journal of Cancer

Accès ouvert 2025 articleOpenAlex

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma

Alexandra Saint‐Charles, Julien Masliah‐Planchon, Elnaz Saberi-Ansari, Angela Bellini et autres

0 citationsJournal of Molecular Diagnostics

2025 articleOpenAlex

Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project

Mallory Taylor, James R. Anderson, Julie R. Park, Meredith S. Irwin et autres

2 citationsPediatric Blood & Cancer

Accès ouvert 2025 otherOpenAlex

Figure S4 from Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma

Jan F. Hollander, Annabell Szymansky, Jasmin Wünschel, Kathy Astrahantseff et autres

0 citations

Accès ouvert 2025 otherOpenAlex

Figure S2 from Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma

Jan F. Hollander, Annabell Szymansky, Jasmin Wünschel, Kathy Astrahantseff et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Data from Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma

Jan F. Hollander, Annabell Szymansky, Jasmin Wünschel, Kathy Astrahantseff et autres

0 citations

Accès ouvert 2025 otherOpenAlex

Figure S3 from Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma

Jan F. Hollander, Annabell Szymansky, Jasmin Wünschel, Kathy Astrahantseff et autres

0 citations

Accès ouvert 2025 otherOpenAlex

Figure S1 from Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma

Jan F. Hollander, Annabell Szymansky, Jasmin Wünschel, Kathy Astrahantseff et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.